• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

SILEXION THERAPEUTICS CORP C/WTS EXP 15/08/2029 (TO PUR COM)(SLXNW.US)

longbridge loading
Overview
News
Company Encyclopedia
View More
name
SILEXION THERAPEUTICS CORP C/WTS EXP 15/08/2029 (TO PUR COM)
SLXNW.US
Shareholder
Ownership%OwnedShare ChgReport Date
No Data
News
View More

SILEXION THERAPEUTICS CORP C/WTS EXP 15/08/2029 (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 0

LB filings·11/12/2025 22:10
US
SLXNW
-5.41%
LB filings·11/12/2025 22:10
US
SLXNW
-5.41%

SILEXION THERAPEUTICS CORP C/WTS EXP 15/08/2029 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0

LB filings·11/12/2025 22:05
US
SLXNW
-5.41%
LB filings·11/12/2025 22:05
US
SLXNW
-5.41%

SILEXION THERAPEUTICS CORP C/WTS EXP 15/08/2029 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD 8.21

LB filings·08/13/2025 04:09
US
SLXNW
-5.41%
LB filings·08/13/2025 04:09
US
SLXNW
-5.41%

SILEXION THERAPEUTICS CORP C/WTS EXP 15/08/2029 (TO PUR COM) | 8-K: FY2025 Q2 EPS: USD -4.32

LB filings·08/12/2025 20:32
US
SLXNW
-5.41%
LB filings·08/12/2025 20:32
US
SLXNW
-5.41%

SILEXION THERAPEUTICS CORP C/WTS EXP 15/08/2029 (TO PUR COM) | 8-K: FY2025 Q1 EPS: USD 0.26

LB filings·05/14/2025 04:56
US
SLXNW
-5.41%
LB filings·05/14/2025 04:56
US
SLXNW
-5.41%
© 2026 Longbridge|Disclaimer